shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Jun 1st - Certificate in Trauma Counselling for Mental Health Professionals: Level 1 trauma certificate [SickKids CCMH Learning Institute]
Jun 4th - Certificate in Cognitive Behaviour Therapy Level 1: Practical solutions to real world problems - live webinar [SickKids CCMH Learning Institute]
Jun 9th - Hack Your Mind for Better Health [MAGentix]
Jun 10th - Tips, Tricks and Techniques for Online Therapy with Children - live 2-hour webinar [SickKids CCMH Learning Institute]
Jun 12th - It’s the Law: What You Need to Know about Consent, Negligence, Confidentiality and more! - webinar [Leading Edge Seminars]
schools agencies and other institutional orders (click here)
Free shipping across Canada, for the foreseeable future. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Progress in Neurotherapeutics and Neuropsychopharmacology, Volume 3 (2008)
Cummings, Jeffrey L. (Edt)
Cambridge University Press / Annual / Journal / 2009-07-01 / 0521115612
Psychopharmacology
reg price: $50.95 our price: $ 48.40 (may be subject to change)
Not in Stock, usually ships in 3-6 business days

Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology.

Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practicing neurologists as well as clinical and translational neuroscientists.

Contents

Contributors; 1. Progress in neurotherapeutics and neuropsychopharmacology Jeffrey L. Cummings; 2. Trifusal versus aspirin for the prevention of stroke Antonio Culebras, Javier Borja and Julián García-Rafanell; 3. The Argatroban and tPA stroke study Andrew D. Barreto and James C. Grotta; 4. Use of Selegiline as monotherapy and in combination with Levodopa in the management of Parkinson’s disease: perspectives from the MONOCOMB study Sven E. Pålhagen and Esa Heinonen; 5. Ropinirole 24-h prolonged release in advanced Parkinson’s disease: review of a randomised, double-blind, placebo-controlled study (EASE PD - adjunct study) Kelly E. Lyons and Rajesh Pahwa; 6. Insulin resistance and Alzheimer’s disease: pathophysiology and treatment G. Stennis Watson and Suzanne Craft; 7. Targeting Amyloid with Tramiprosate in patients with mild-to-moderate Alzheimer’s disease P. S. Aisen, R. Briand, D. Saumier, J. Laurin, A. Duong and D. Garceau; 8. Intranasal Zolmitriptan is effective and well-tolerated in acute cluster headache: a randomized placebo-controlled double-blind crossover study E. Cittadini and P. J. Goadsby; 9. Optimal dosing of immunomodulating drugs: a dose-comparison study of GA in RRMS Daniel Wynn, Catherine Meyer, Neil Allen and Dennis O’Brien; 10. Tetrathiomolybdate versus Trientine in the initial treatment of neurologic Wilson’s disease George J. Brewer, Fred Askari, Matthew T. Lorincz, Martha Carlson, Michael Schilsky, Karen J. Kluin, Peter Hedera, Paolo Moretti, John K. Fink, Roberta Tankanow, Robert B. Dick and Julia Sitterly; 11. Randomized clinical trials of Pregabalin for neuropathic pain: methods, results, and implications Robert H. Dworkin, Rajbala Thakur, Teresa Griesing, Uma Sharma and James P. Young; 12. Effect of Methylphenidate in patients with acute traumatic brain injury: a randomized clinical trial Hossein A. Khalili and Kamyar Keramatian; 13. Improvement in speeded cognitive processing after anti-epileptic drug withdrawal - a controlled study in mono-therapy patients Erik Hessen, Morten I. Lossius, Ivar Reinvang and Leif Gjerstad; 14. A randomized-controlled trial of bilateral rTMS for treatment-resistant depression Paul B. Fitzgerald; 15. Serotonin related genes affect antidepressant treatment in obsessive-compulsive disorder F. Van Nieuwerburgh, D. Deforce and D. A. J. P. Denys; 16. Night eating syndrome and results from the first placebo-controlled trial of treatment, with the SSRI medication, Sertraline: implications for clinical practice John P. O’Reardon Karen E. Groff, Albert J. Stunkard and Kelly C. Allison; 17. Modafinil: a candidate for pharmacotherapy of negative symptoms in schizophrenia John H. Peloian and Joseph M. Pierre; 18. New approaches to treatment of schizophrenia by enhancing N-methyl-D-aspartate neurotransmission Guochuan Emil Tsai; Subject index; Author index.

Contributors

Jeffrey L. Cummings, Antonio Culebras, Javier Borja, Julián García-Rafanell, Andrew D. Barreto, James C. Grotta, Sven E. Pålhagen, Esa Heinonen, Kelly E. Lyons, Rajesh Pahwa, G. Stennis Watson, Suzanne Craft, P. S. Aisen, R. Briand, D. Saumier, J. Laurin, A. Duong, D. Garceau, E. Cittadini, P. J. Goadsby, Daniel Wynn, Catherine Meyer, Neil Allen, Dennis O’Brien, George J. Brewer, Fred Askari, Matthew T. Lorincz, Martha Carlson, Michael Schilsky, Karen J. Kluin, Peter Hedera, Paolo Moretti, John K. Fink, Roberta Tankanow, Robert B. Dick, Julia Sitterly, Robert H. Dworkin, Rajbala Thakur, Teresa Griesing, Uma Sharma, James P. Young, Hossein A. Khalili, Kamyar Keramatian, Erik Hessen, Morten I. Lossius, Ivar Reinvang, Leif Gjerstad, Paul B. Fitzgerald, F. Van Nieuwerburgh, D. Deforce, D. A. J. P. Denys, John P. O’Reardon, Karen E. Groff, Albert J. Stunkard, Kelly C. Allison, John H. Peloian, Joseph M. Pierre, Guochuan Emil Tsai

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / Closed Sunday (EST)

search
Click here to read previous issues.
authors
Cummings, Jeffrey L
other lists
Cambridge University Press
Psychopharmacology
University Presses